Korea Quantum Computing (hereinafter KQC), a company specializing in quantum computing R&D, quantum security, and AI infrastructure operations, announced that it has signed a Memorandum of Understanding (MOU) with the Korean Society for Bioinformatics (KSBI; President Sungho Ryu) to collaborate on bioinformatics research using quantum computing. The agreement was signed during BIOINFO 2025, KSBI’s annual scientific conference, held from October 14 to 17 at the Suwon Convention Center.

KSBI is Korea’s leading academic society in bioinformatics and systems biology, dedicated to advancing research, international collaboration, and professional talent development. KQC, meanwhile, leads the development of quantum computing infrastructure and industry networks in Korea. This partnership marks the first academic-level collaboration in Korea to formally introduce quantum computing into the field of bioinformatics.

Through the MOU, the two organizations aim to apply the computational power of quantum computing to complex bioinformatics challenges, including drug discovery, genomic analysis, and protein structure prediction. In particular, they plan to integrate quantum algorithms into KSBI’s focus areas of AI Bio and Digital Bio, accelerating large-scale molecular simulations and drug–protein interaction analysis that are difficult to address with classical computing alone.

Key areas of collaboration include:

• Quantum computing–based drug design algorithms

• Quantum–AI hybrid algorithms for genomic data analysis

• Optimization of lead compound discovery in cheminformatics

• Molecular network analysis in systems biology

• Quantum computing education programs for bioinformatics researchers

• 
  

Sungho Ryu, President of KSBI, said, “Quantum computing has the potential to transform the paradigm of bioinformatics research. Through this partnership with KQC, KSBI aims to take a leading role in AI Bio and Digital Bio and contribute meaningfully to national R&D priorities.”

Jay J.H. Kweon, Chairman of KQC, added, “By leveraging KQC’s quantum computing access infrastructure and experience in developing quantum algorithms for bio and pharmaceutical applications, we will actively support KSBI researchers in applying quantum computing to real-world research. This collaboration represents an important step in expanding the industrial application of quantum computing into the life sciences.”

KQC is a leading Korean quantum technology company operating businesses across quantum computing, AI data centers, and quantum security, providing next-generation security solutions such as PQC-HSM and FIDO authentication.